Скачать или смотреть Gene Market Multiplies: Buy this Genetics Stock Now

Research analyst Matt Clark takes a look at DNA and explains how you can use the building blocks of life to build your portfolio. In today’s episode, Matt discusses the booming genetics and genomics sectors and chooses a stock with a lot of promise. Matt also runs the stock through Chief Investment Strategist Adam O’Dell's Six-Factor Green Zone Ratings system. 

Timestamps: 
3:03: Genetics and Genomics Market 
4:10: ARK Genomic Revolution Multi-Sector ETF (NYSE: ARKG)
5:30: Fulgent Genetics Inc (NASDAQ: FLGT)
7:16: Adam Odell’s Six-Factor Green Zone Rating system


Sign up for FREE access to our Money & Markets daily emails to start your journey to more profitable investing! https://moneyandmarkets.com/


Click here to learn more about Adam O'dell's Green Zone Rating System: https://pro.moneyandmarkets.com/m/172...


About Matt Clark: Matt Clark is a 25-year journalism veteran covering topics from college sports to politics and business. Over the course of his career, he has been awarded for investigative journalism, business reporting, editorial writing and sports coverage. Now, he’s the research analyst for Money & Markets, where he also hosts The Bull & The Bear podcast — available on Apple Podcasts, Spotify and Google Podcasts.


Follow Money & Markets on Social Media!
Facebook:   / moneyandmarkets  
Twitter:   / themoneymarkets  
Instagram:   / themoneymarkets  


Leave a comment below, or send an email to [email protected] to let us know which stock you'd like us to cover!


#FLGT #ARKG #TheBullandTheBear #Stocks #Investing